Bioscience Company Announces Successful FDA Meeting For Opioid Overdose Protection

Ensysce Biosciences Makes Strides in Opioid Overdose Protection with Successful FDA Meeting for PF614-MPAR.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an unprecedented move towards improving opioid safety, Ensysce Biosciences Inc. ($ENSC) recently announced a successful meeting with the U.S. Food and Drug Administration (FDA) regarding its next-generation…